Deutsche Bank
STRO icon

Deutsche Bank’s Sutro Biopharma STRO Stock Holding History

Deutsche Bank’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$517K Buy
+15,563
New +$485K ﹤0.01% 2758
2024
Q4 		– Sell
-4,253
Closed -$147K – 3700
2024
Q3 		$147K Buy
4,253
+1,435
+51% +$56.3K ﹤0.01% 3068
2024
Q2 		$82.6K Sell
2,818
-561
-17% -$22.2K ﹤0.01% 3175
2024
Q1 		$191K Buy
3,379
+122
+4% +$5.39K ﹤0.01% 2844
2023
Q4 		$140K Sell
3,257
-121
-4% -$3.84K ﹤0.01% 3061
2023
Q3 		$117K Buy
3,378
+585
+21% +$25.5K ﹤0.01% 3083
2023
Q2 		$130K Sell
2,793
-495
-15% -$24.6K ﹤0.01% 3133
2023
Q1 		$152K Buy
3,288
+1,000
+44% +$63.5K ﹤0.01% 3133
2022
Q4 		$185K Buy
2,288
+517
+29% +$35.9K ﹤0.01% 3022
2022
Q3 		$98K Sell
1,771
-294
-14% -$17.4K ﹤0.01% 3330
2022
Q2 		$108K Sell
2,065
-314
-13% -$17.5K ﹤0.01% 3492
2022
Q1 		$195K Sell
2,379
-3,336
-58% -$317K ﹤0.01% 3283
2021
Q4 		$850K Buy
5,715
+140
+3% +$25.1K ﹤0.01% 2537
2021
Q3 		$1.05M Sell
5,575
-80
-1% -$15.2K ﹤0.01% 2572
2021
Q2 		$1.05M Sell
5,655
-6,026
-52% -$1.18M ﹤0.01% 2736
2021
Q1 		$2.66M Sell
11,681
-8
-0.1% -$1.9K ﹤0.01% 1957
2020
Q4 		$2.54M Buy
11,689
+10,274
+726% +$1.7M ﹤0.01% 1780
2020
Q3 		$143K Buy
1,415
+593
+72% +$56K ﹤0.01% 3388
2020
Q2 		$64K Buy
822
+484
+143% +$46.4K ﹤0.01% 3690
2020
Q1 		$34K Sell
338
-418
-55% -$43.9K ﹤0.01% 3722
2019
Q4 		$82K Buy
756
+470
+164% +$48.5K ﹤0.01% 3677
2019
Q3 		$25K Sell
286
-605
-68% -$61.1K ﹤0.01% 4244
2019
Q2 		$100K Sell
891
-44
-5% -$4.85K ﹤0.01% 4209
2019
Q1 		$105K Sell
935
-47
-5% -$4.89K ﹤0.01% 4288
2018
Q4 		$87K Buy
+982
New +$119K ﹤0.01% 4280

Other funds holding STRO

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Deutsche Bank's STRO Position: Q2 2026 in Review

Deutsche Bank opened a new position in Sutro Biopharma (STRO) in Q2 2026: 15,563 shares worth $517K. The stake represents ﹤0.01% of the portfolio and ranks #2758 among its holdings. This is a return to the name: Deutsche Bank previously reported a position in STRO as recently as Q3 2024.

Deutsche Bank first reported a position in STRO in Q4 2018 and has held it in 25 quarters since. The position peaked at $2.66M in Q1 2021. 100 funds tracked by Wall St. Rank hold STRO as of Q2 2026.

  • Deutsche Bank held 15,563 shares of Sutro Biopharma worth $517K as of Q2 2026.
  • Sutro Biopharma was a new Deutsche Bank position in Q2 2026.
  • Sutro Biopharma made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2758 holding.
  • Deutsche Bank first reported a position in Sutro Biopharma in Q4 2018 and has held it in 25 quarters since.
  • Deutsche Bank's Sutro Biopharma position peaked at $2.66M in Q1 2021.
  • 100 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.